Clinical Trial Update: An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery [Phase 3]

View source ↗

Summary

Phase 3 open-study assessing safety and efficacy of Replenine-VF in haemophilia B patients undergoing surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Replenine®-VF (Factor IX concentrate)

Snippet

Sponsor: Bio Products Laboratory | Conditions: Haemophilia B | Phase 3 | Status: COMPLETED